These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8946001)

  • 1. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury.
    Kelly KJ; Tolkoff-Rubin NE; Rubin RH; Williams WW; Meehan SM; Meschter CL; Christenson JG; Bonventre JV
    Am J Physiol; 1996 Nov; 271(5 Pt 2):F1061-7. PubMed ID: 8946001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
    Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM
    Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.
    Kelly KJ; Williams WW; Colvin RB; Bonventre JV
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):812-6. PubMed ID: 7904759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
    Yin M; Buurman WA; Daemen JW; Kootstra G
    Transplantation; 1996 May; 61(10):1443-6. PubMed ID: 8633367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor protects the kidney against ischemia-reperfusion injury.
    Cuevas P; Martinez-Coso V; Fu X; Orte L; Reimers D; Giménez-Gallego G; Forssmann WG; Saenz De Tejada I
    Eur J Med Res; 1999 Oct; 4(10):403-10. PubMed ID: 10527953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion.
    Suzuki S; Serizawa A; Sakaguchi T; Tsuchiya Y; Kojima Y; Okamoto K; Kurachi K; Konno H; Fujise Y; Baba S; Nakamura S
    Transplantation; 2000 Jun; 69(11):2267-73. PubMed ID: 10868624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE; Metcalfe S; Ramirez-Romero P; Calne R; Jamieson NV
    Transplantation; 1994 May; 57(10):1440-4. PubMed ID: 8197604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
    Sun Z; Wang X; Lasson A; Böjesson A; Annborn M; Andersson R
    Scand J Gastroenterol; 2001 Jan; 36(1):55-65. PubMed ID: 11218240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.
    Arumugam TV; Shiels IA; Strachan AJ; Abbenante G; Fairlie DP; Taylor SM
    Kidney Int; 2003 Jan; 63(1):134-42. PubMed ID: 12472776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury.
    Rabb H; Mendiola CC; Saba SR; Dietz JR; Smith CW; Bonventre JV; Ramirez G
    Biochem Biophys Res Commun; 1995 Jun; 211(1):67-73. PubMed ID: 7779111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury.
    Ghielli M; Verstrepen WA; De Greef KE; Helbert MH; Ysebaert DK; Nouwen EJ; De Broe ME
    Kidney Int; 2000 Sep; 58(3):1121-34. PubMed ID: 10972676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
    MacKendrick W; Caplan M; Hsueh W
    Pediatr Res; 1993 Aug; 34(2):222-8. PubMed ID: 8233729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats.
    Wang KS; Monden M; Kanai T; Gotoh M; Umeshita K; Ukei T; Mori T
    Surgery; 1993 Jan; 113(1):76-83. PubMed ID: 8417492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
    Olanders K; Börjesson A; Sun ZW; Andersson R
    Scand J Gastroenterol; 2003 Jun; 38(6):618-25. PubMed ID: 12825870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the combination of Ro 24-5913, a peptidoleukotriene antagonist, and Ro 24-4736, a PAF antagonist, in guinea pig and rat models of lung inflammation.
    Welton AF; O'Donnell M; Renzetti L; Simko B; Tocker J; Cashin C; Newbold P; Wasserman MA
    Ann N Y Acad Sci; 1994 Nov; 744():274-88. PubMed ID: 7825850
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat.
    Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC
    Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment.
    Lloberas N; Torras J; Herrero-Fresneda I; Cruzado JM; Riera M; Hurtado I; Grinyó JM
    FASEB J; 2002 Jun; 16(8):908-10. PubMed ID: 12039876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.